Positive Patient Stories™

SEC Filings

<< Back
Form 424B5
PARATEK PHARMACEUTICALS, INC. filed this Form 424B5 on 03/03/2017
Document Outline
Entire Document (426.5 KB)
Subdocument 1 - 424B5 - 424B5
Page 1 - As Filed Pursuant to Rule 424(b)(5)
Page 2 - TABLE OF CONTENTS
Page 3 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 4 - N/A
Page 5 - PROSPECTUS SUPPLEMENT SUMMARY
Page 6 - Risks Associated with our Business
Page 7 - The Offering
Page 8 - RISK FACTORS
Page 9 - You may experience immediate dilution in the book value per share of the common stock you purchase.
Page 10 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 11 - N/A
Page 12 - USE OF PROCEEDS
Page 13 - DILUTION
Page 14 - N/A
Page 15 - PLAN OF DISTRIBUTION
Page 16 - LEGAL MATTERS
Page 17 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 18 - Prospectus
Page 19 - TABLE OF CONTENTS
Page 20 - N/A
Page 21 - PROSPECTUS SUMMARY
Page 22 - Risks Associated with our Business
Page 23 - Corporate Information
Page 24 - Common Stock.
Page 25 - Warrants.
Page 26 - RISK FACTORS
Page 27 - N/A
Page 28 - USE OF PROCEEDS
Page 29 - RATIO OF COMBINED FIXED CHARGES TO EARNINGS
Page 30 - DESCRIPTION OF CAPITAL STOCK
Page 31 - Anti-Takeover Effects of Provisions of Delaware Law and Our Charter Documents
Page 32 - Charter Documents
Page 33 - Transfer Agent and Registrar
Page 34 - DESCRIPTION OF DEBT SECURITIES
Page 35 - N/A
Page 36 - Conversion or Exchange Rights
Page 37 - Modification of Indenture; Waiver
Page 38 - Discharge
Page 39 - Form, Exchange and Transfer
Page 40 - Payment and Paying Agents
Page 41 - DESCRIPTION OF WARRANTS
Page 42 - Exercise of Warrants
Page 43 - N/A
Page 44 - N/A
Page 45 - LEGAL MATTERS
Page 46 - N/A
Page 47 - Up to $50,000,000 of Shares

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.